PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2017 | 50 |
| 2018 | 86 |
| 2019 | 111 |
| 2020 | 96 |
| 2021 | 144 |
| 2022 | 150 |
| 2023 | 127 |
| 2024 | 167 |
| 2025 | 184 |
| 2026 | 140 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"JCO Precis Oncol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Prospective Study of Annual Whole-Body Magnetic Resonance Imaging as Part of a Multimodality Screening Program for Individuals With Li-Fraumeni Syndrome.
- Maoz A, Chen N, Umaretiya P, Cahill SR, Schwartz-Levine A, Jagannathan J, Voss SD, Friedman DN, Walsh M, Robson ME, Nehoray B, Frone MN, Schneider KA, Schienda JM, Hamilton KV, Onufrychuk A, Diller LR, Kamihara J, Rana HQ, Garber JE, London WB, O'Neill AF.
- JCO Precis Oncol. 2025 Oct 23;9:e2500264. doi: 10.1200/PO-25-00264.
- PMCID: PMC12560191
Maoz A, et al.JCO Precis Oncol. 2025.PMCID: PMC12560191 -
Role of Novel Bispecific Antibodies and Immunotherapy in Non-Small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations.
- Su PL, Xu P, Lin CC, Rolfo C, Carbone DP, He K.
- JCO Precis Oncol. 2025 Oct 23;9:e2500023. doi: 10.1200/PO-25-00023.
- PMCID: PMC12560187
Su PL, et al.JCO Precis Oncol. 2025.PMCID: PMC12560187 -
Medulloblastoma Spatial Transcriptomics Reveals Tumor Microenvironment Heterogeneity With High-Density Progenitor Cell Regions Correlating With High-Risk Disease.
- Chien F, Michaud ME, Bakhtiari M, Schroff C, Snuderl M, Velazquez Vega JE, MacDonald TJ, Bhasin MK.
- JCO Precis Oncol. 2026 Oct 13;10(10):e2501195. doi: 10.1200/PO-25-01195.
- PMCID: PMC13686638
Chien F, et al.JCO Precis Oncol. 2026.PMCID: PMC13686638 -
Genomic Analysis Using Liquid Biopsy: Considerations for Pretest Counseling in UK Practice.
- McMahon DJ, Bancroft E, Burghel GJ, Copson E, Hubank M, Wiggins J, Snape K, Cook N, Frayling I, Murray MJ, Greystoke A, Krebs MG, Popat S, McVeigh TP; UK Circulating Biomarkers Network of Excellence and the National ctDNA Steering Committee.
- JCO Precis Oncol. 2026 Oct 7;10(10):e2600366. doi: 10.1200/PO-26-00366.
- PMCID: PMC13668035
McMahon DJ, et al.JCO Precis Oncol. 2026.PMCID: PMC13668035 -
Tailoring Escalated Adjuvant Chemotherapy for Multifocal and Multicentric Breast Cancer With Low Tumor Burden.
- Su Y, Ying J, Zhan Z, Wu T, Yu Y, Gao W, Zheng Y.
- JCO Precis Oncol. 2026 Oct 7;10(10):e2600177. doi: 10.1200/PO-26-00177.
- PMCID: PMC13668041
Su Y, et al.JCO Precis Oncol. 2026.PMCID: PMC13668041 -
Determining the Causal Effect of Neurotrophic Tropomyosin Receptor Kinase Gene Fusions on Survival Prognosis for Adult Patients With Advanced Cancers.
- Krebs E, Tamvada N, Weymann D, Lim HJ, Chia S, Ho C, Regier DA.
- JCO Precis Oncol. 2026 Oct 7;10(10):e2600281. doi: 10.1200/PO-26-00281.
- PMCID: PMC13668040
Krebs E, et al.JCO Precis Oncol. 2026.PMCID: PMC13668040 -
Evaluating the Prognostic Impact of IDH Mutations in Intrahepatic Cholangiocarcinoma.
- Harvey RN, Gelfer R, Drill E, Balachandran V, D'Angelica M, Drebin J, Kingham TP, Saadat L, Soares K, Wei AC, Abou-Alfa GK, Cercek A, Harding JJ, O'Reilly EM, Doukas M, Homs MYV, Groot Koerkamp B, Jarnagin WR.
- JCO Precis Oncol. Author manuscript. 2026 Aug 4;10(8):e2501261. doi: 10.1200/PO-25-01261.
- PMCID: PMC13662602
Harvey RN, et al.JCO Precis Oncol. Author manuscript. 2026.PMCID: PMC13662602 -
Type II RAF Inhibitor Tovorafenib in Recurrent/Refractory Melanoma or Other Solid Tumors With BRAF Fusions or CRAF/RAF1 Fusions or Amplification: Phase II FIRELIGHT-1 Substudy.
- Vieito M, Cabanas EG, Mehmi I, Gaudy-Marqueste C, O'Neil BH, Medina TM, Body AL, Arance A, Kummar S, Najjar YG, Bedard PL, Rankin A, Chu C, McKenna C, Hume S, Kopp LM, Lee J.
- JCO Precis Oncol. 2026 Oct 2;10(10):e2501187. doi: 10.1200/PO-25-01187.
- PMCID: PMC13657394
Vieito M, et al.JCO Precis Oncol. 2026.PMCID: PMC13657394 -
Tumor-Free Circulating Tumor DNA in Node-Negative Rectal Cancers Undergoing Neoadjuvant Chemotherapy, Excision, and Observation in the Phase II NEO Trial (CO.28).
- Loree JM, Titmuss E, Brown CJ, Rich T, Banks K, Gordon V, Patel S, Krahn M, Caycedo-Marulanda A, Raval M, Tu D, Jonker DJ, O'Callaghan CJ, Kennecke HF.
- JCO Precis Oncol. 2026 Oct 2;10(10):e2600459. doi: 10.1200/PO-26-00459.
- PMCID: PMC13657393
Loree JM, et al.JCO Precis Oncol. 2026.PMCID: PMC13657393 -
Decoding Treatment Response and Prognosis in Unresectable Locally Advanced Non-Small Cell Lung Cancer by Integrating Spatiotemporal Heterogeneity From 18F-FDG Positron Emission Tomography-Computed Tomography: A Multicenter Study.
- Ji Y, Wang J, Zhou M, Wang Y, Dai Z, Zheng J.
- JCO Precis Oncol. 2026 Oct 2;10(10):e2600609. doi: 10.1200/PO-26-00609.
- PMCID: PMC13657396
Ji Y, et al.JCO Precis Oncol. 2026.PMCID: PMC13657396